Synthetic Bacteria Vaccine Against Antibiotics Resistant Bacteria
Key Problem and Market Opportunity
Some pseudaminic acid bacteria, such as Acinetobacter baumannii, Pseudomonas aeruginosa were listed as “priority list” by WHO. However there are a lack of effective antibiotics to treat them.
Key Advantages of the Technology
The underlying mechanism is a conjugation of pseudaminic acid which exits in pathogens to a carrier protein CRM197 to form anti-bacteria conjugate vaccines.
- Promising protection efficacy
Potential Product and Services
Vaccine for Pse carrying bacteria, e.g. Acinetobacter baumannii, Pseudomonas aeruginosa, and Campylobacter jejuni.
Development Status and IP Strength
- US provision application
- Patent application submitted